204 related articles for article (PubMed ID: 8862587)
1. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.
Mitchell LA; Ho MK; Rogers JE; Tingle AJ; Marusyk RG; Weber JM; Duclos P; Tepper ML; Lacroix M; Zrein M
J Clin Microbiol; 1996 Sep; 34(9):2210-8. PubMed ID: 8862587
[TBL] [Abstract][Full Text] [Related]
2. Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations.
Mitchell LA; Tingle AJ; Grace M; Middleton P; Chalmers AC
J Rheumatol; 2000 Feb; 27(2):418-23. PubMed ID: 10685808
[TBL] [Abstract][Full Text] [Related]
3. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.
Mitchell LA; Zhang T; Ho M; Décarie D; Tingle AJ; Zrein M; Lacroix M
J Clin Microbiol; 1992 Jul; 30(7):1841-7. PubMed ID: 1629342
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in antibody- and cell-mediated immune response to rubella re-immunisation.
Mitchell LA
J Med Microbiol; 1999 Dec; 48(12):1075-1080. PubMed ID: 10591160
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination.
Zrein M; Joncas JH; Pedneault L; Robillard L; Dwyer RJ; Lacroix M
J Clin Microbiol; 1993 Jun; 31(6):1521-4. PubMed ID: 8314994
[TBL] [Abstract][Full Text] [Related]
6. Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells.
Nedeljkovic J; Jovanovic T; Mladjenovic S; Hedman K; Peitsaro N; Oker-Blom C
J Clin Virol; 1999 Oct; 14(2):119-31. PubMed ID: 10588454
[TBL] [Abstract][Full Text] [Related]
7. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
Tischer A; Gerike E
Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
[TBL] [Abstract][Full Text] [Related]
8. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
[TBL] [Abstract][Full Text] [Related]
9. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
Davidkin I; Peltola H; Leinikki P; Valle M
Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790
[TBL] [Abstract][Full Text] [Related]
10. Maturation of IgG avidity to individual rubella virus structural proteins.
Nedeljkovic J; Jovanovic T; Oker-Blom C
J Clin Virol; 2001 Aug; 22(1):47-54. PubMed ID: 11418352
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and durability of rubella virus antibodies in a highly immunized population.
Crooke SN; Haralambieva IH; Grill DE; Ovsyannikova IG; Kennedy RB; Poland GA
Vaccine; 2019 Jun; 37(29):3876-3882. PubMed ID: 31126859
[TBL] [Abstract][Full Text] [Related]
12. Determination of rubella virus-specific humoral and cell-mediated immunity in pregnant women with negative or equivocal rubella-specific IgG in routine screening.
Picone O; Bouthry E; Bejaoui-Olhmann Y; Cordier AG; Nedellec S; Letourneau A; Carbonel M; Brollo M; Grangeot-Keros L; Ayoubi JM; Benachi A; Rouge E; Vauloup-Fellous C
J Clin Virol; 2019 Mar; 112():27-33. PubMed ID: 30711798
[TBL] [Abstract][Full Text] [Related]
13. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
14. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
Haralambieva IH; Ovsyannikova IG; Kennedy RB; Goergen KM; Grill DE; Chen MH; Hao L; Icenogle J; Poland GA
Vaccine; 2020 Jan; 38(5):1249-1257. PubMed ID: 31732325
[TBL] [Abstract][Full Text] [Related]
15. Differential antibody responses to rubella virus infection in males and females.
Mitchell LA; Zhang T; Tingle AJ
J Infect Dis; 1992 Dec; 166(6):1258-65. PubMed ID: 1431244
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
[TBL] [Abstract][Full Text] [Related]
17. Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection.
Takahashi S; Machikawa F; Noda A; Oda T; Tachikawa T
Clin Diagn Lab Immunol; 1998 Jan; 5(1):24-7. PubMed ID: 9455874
[TBL] [Abstract][Full Text] [Related]
18. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
[TBL] [Abstract][Full Text] [Related]
19. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome.
Mauracher CA; Mitchell LA; Tingle AJ
J Immunol; 1993 Aug; 151(4):2041-9. PubMed ID: 8345195
[TBL] [Abstract][Full Text] [Related]
20. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
